Logos Global Management »

Arcus Biosciences Incorporated shares owned by Logos Global Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Logos Global Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.2M 325k 19.10
2023-06-30 $15M 750k 20.31

More positions owned by Logos Global Management

Cytokinetics Com New (CYTK)
Apellis Pharmaceuticals (APLS)
Sarepta Therapeutics Call Option (SRPT)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Olema Pharmaceuticals (OLMA)
Immunovant (IMVT)
Structure Therapeutics Sponsored Ads (GPCR)
Rocket Pharmaceuticals (RCKT)
Rayzebio
Ambrx Biopharma
Karuna Therapeutics Ord
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Morphosys Sponsored Ads Call Option (MOR)

View all positions for Logos Global Management

Top funds holding Arcus Biosciences Incorporated

Vanguard Group
Octagon Capital Advisors
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Decheng Capital
Point72 Asset Management
Goldman Sachs Group
Bnp Paribas Investment Partners
Balyasny Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Ikarian Capital
Ubs Global Asset Management Americas

View all funds holding Arcus Biosciences Incorporated